"Alerted.org

The Executive Director, Product Strategy and Valuation position will lead a team of approximately six individuals and be part of the GCSO Leadership Team. This role will be responsible for guiding the team to build commercial and business case assessments for both business development opportunities and internal pipeline programs and for playing a leadership role at BeOne Portfolio Review Committee (BPRC). This role will also assist with/leading certain ad-hoc cross-functional initiatives.

Essential Functions & Responsibilities:

Primary responsibilities include but are not limited to:

+ Lead pipeline commercial assessment acrossall therapeutic areas and development stages for enterprise planning and annual LRP purposes

+ Support commercial assessments through appropriate insight generation and subsequent quantification of the opportunity, with clear articulation of key assumptions / value drivers / risk parameters

+ Engagewith key stakeholders across R&D and commercial teams to ensure visibility of key assumptionsand resulting project-related forecasts. Develop strong working relationships with key partners such as Pricing/Access, GCSO franchise teams,CBDI and GPPM to ensure cross-functional perspectives are incorporated within commercial assessments

+ Develop portfolio-level view of BeOne pipeline to ensure thorough understanding of the impact upon commercial assessments arising fromoverlapping development plans, or through cannibalization of later lines of therapy as asset LCM plans move into earlier treatment settings

+ Drive quantitative and support qualitative commercial input at both the indication and program levels to inform portfolio prioritization; collaborate with GPPM to develop informative and effective multidisciplinary portfolio prioritization framework and process

+ Support the commercial and business case assessments for major pipeline investment decisions at the BPRClevel and to inform go-no-go decisions at DRC, ERC, and program team (i.e. GPT, DCT, EDT, BU) levels, working cross functionally with R&D and GCSO team members

+ Partner with both global commercial franchise teams and BD to support commercial assessment for globalbusiness development activities, covering all deal types and targets/assets at all development stages

+ Inform and influence TPP/CDP development, Disease Area Strategies and asset-level strategy formulation by synthesizing insights from primary market research, treatment/competitive landscape monitoring and commercial assessment-based analytics

+ Manage budget, AOP and LRP for the full team

Education Required:

+ Advanced degrees in life sciences and/or business

Required Experience:

+ MS Degree with a minimum of 10 plus years of relevant experience in commercial assessment/new product planning/disease area strategy/early commercialization from the pharmaceutical industry, consulting, or equity analyst roles

+ Oncology and Immunology & inflammatory disease area knowledge/experience strongly preferred

+ Proficient in both primary and secondary market research

+ Demonstrated track-record in indication-, and patient-level forecasting methodologies

+ Excellent communication skills and strong analytical skills required to analyze scientific and financial data, synthesize insights and stories behind the data, and prepare precise as well as concise presentations for senior executives’ review

+ Experience of working in a cross-functional setting

+ Ability to work on multiple projects simultaneously and effectively prioritize work

+ Ability to work in a rapidly changing environment

+ Excellent learning capability and aspiration for excellence

Locations:

+ This is remote work-from-home position, provided the candidate’s residence is within the US and individual has ability to travel and go into BeOne office as needed

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.